Search


EMA Guidance: Pre-Authorisation Procedural Advice for Users of the Centralised Procedure
The European Medicines Agency (EMA)Â has issued comprehensive guidance " European Medicines Agency Pre-Authorisation Procedural Advice for...

Sharan Murugan
Dec 21, 20243 min read
Â
Â


UK MHRA Guidance: Variations to Marketing Authorisations (MAs)
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published (20 December 2024) updated guidance " Variations to...

Sharan Murugan
Dec 21, 20242 min read
Â
Â


USFDA Guidance: Technical Specifications for Submitting Clinical Trial Data Sets for Treatment of Noncirrhotic Nonalcoholic Steatohepatitis (NASH)
The U.S. Food and Drug Administration (FDA)Â has released a guidance " Technical Specifications for Submitting Clinical Trial Data Sets...

Sharan Murugan
Dec 15, 20242 min read
Â
Â


UK MHRA Guidance: Applying for a Licence to Market a Medicine in the UK
The Medicines and Healthcare Products Regulatory Agency (MHRA) Â has published updated guidance " Applying for a Licence to Market a...

Sharan Murugan
Dec 15, 20242 min read
Â
Â


USFDA: CDER Establishes New Center for Real-World Evidence Innovation (CCRI)
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER)  has unveiled an innovative initiative—the CDER...

Sharan Murugan
Dec 15, 20242 min read
Â
Â


USFDA Guidance: Standardized Format for Electronic Submission of NDA and BLA Content for Bioresearch Monitoring (BIMO) Inspections
The United States Food and Drug Administration (USFDA)Â has released detailed guidance" Standardized Format for Electronic Submission of...

Sharan Murugan
Dec 9, 20242 min read
Â
Â


USFDA Draft Guidance: Accelerated Approval – Expedited Program for Serious Conditions
The United States Food and Drug Administration (USFDA) has released (05 December, 2024) the draft guidance " Expedited Program for...

Sharan Murugan
Dec 9, 20242 min read
Â
Â


USFDA Guidance: Enhancing Communication and Guidance Development Practices
The US Food and Drug Administration (USFDA) Â has released two insightful reports aimed at improving its internal practices and...

Sharan Murugan
Dec 4, 20242 min read
Â
Â


UK MHRA Press Release Trials Innovative AI Technologies in Regulatory Pilot Scheme
The UK Medicines and Healthcare Products Regulatory Agency (MHRA)Â has launched (4th December 2024) a groundbreaking pilot scheme "...

Sharan Murugan
Dec 4, 20242 min read
Â
Â


ICH Seeks Market Consultation for Global Post-Approval CMC Assessment Cloud Solution
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)Â has issued a Request for...

Sharan Murugan
Nov 30, 20242 min read
Â
Â


EMA Guidance: Scientific Guidelines with Summary of Product Characteristics (SmPC) Recommendations
The European Medicines Agency (EMA) Â has released a comprehensive document " Scientific guidelines with summary-of-product-characteristi...

Sharan Murugan
Nov 30, 20242 min read
Â
Â


UK MHRA Issues Final Call to Comply with Windsor Framework for Medicines by January 2025
The UK Medicines and Healthcare Products Regulatory Agency (MHRA)Â has issued " Call to comply with Windsor Framework arrangements for...

Sharan Murugan
Nov 29, 20242 min read
Â
Â


USFDA: Guidances to Advance Drug Development and Safety Assessments Advance Drug Development and Safety Assessments
The USFDA Â continues to innovate its regulatory landscape with the release of three important guidance earlier today (27 November, 2024)...

Sharan Murugan
Nov 27, 20242 min read
Â
Â


Australia's TGA: Listed Medicines Evidence Guidelines
Earlier today (20 November, 2024) the Therapeutic Goods Administration (TGA)Â released Version 4.0 of its Listed Medicines " Evidence...

Sharan Murugan
Nov 20, 20242 min read
Â
Â


Swissmedic Guidance on Product Information for Human Medicinal Products
Swissmedic, the Swiss Agency for Therapeutic Products, has introduced its updated guidance  on " Product Information for Human Medicinal...

Sharan Murugan
Nov 16, 20242 min read
Â
Â


UK MHRA Guidance: How Marketing Authorisation Applications referred under Article 29 are Handled
The UK MHRA updated its Guidance on " How Marketing Authorisation Applications referred under Article 29 are Handled " and outlines the...

Sharan Murugan
Nov 16, 20242 min read
Â
Â


South Africa's SAHPRA: Communication to Industry on Quality Variations
The SAHPRA released a " Communication to Industry on Quality Variations "Â document that addresses updates on the submission requirements...

Sharan Murugan
Nov 11, 20242 min read
Â
Â


South Africa-SAHPRA: Engagement Portal
As part of the South African Health Product Regulatory Authority’s (SAHPRA) Digitalisation Project, we launched the SAHPRA Engagement...

Sharan Murugan
Nov 9, 20242 min read
Â
Â


USFDA Guidance: Study Data Technical Conformance Guide - Technical Specifications
The Study Data Technical Conformance Guide (SDTCG)Â from the USFDA provides a framework to help sponsors submit standardized study data...

Sharan Murugan
Nov 9, 20242 min read
Â
Â


Australia's TGA Good Clinical Practice (GCP) Inspection Program
Recently last week (30 October, 2024) the TGA released an updated reference material about the " Good Clinical Practice (GCP) Inspection...

Sharan Murugan
Nov 3, 20242 min read
Â
Â
